Investigation of the correlation between diabetic retinopathy and prevalent and incident migraine in a national cohort study
暂无分享,去创建一个
Kenneth H. Rubin | J. Grauslund | R. Kawasaki | S. Möller | K. Højlund | S. Heegaard | C. Laugesen | Lonny Stokholm | K. Schielke | A. S. Vergmann | A. Thykjær | L. Stokholm
[1] X. Shu,et al. Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy , 2021, Neuropharmacology.
[2] K. Zorena,et al. Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients , 2021, Journal of clinical medicine.
[3] K. Hagen,et al. Migraine, obesity and body fat distribution – a population-based study , 2020, The Journal of Headache and Pain.
[4] J. Grauslund,et al. Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): study perspective. , 2020, Acta ophthalmologica.
[5] Ana Maria Blanco Martinez,et al. Neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: galectin-3 participation , 2019, Neural regeneration research.
[6] L. Edvinsson,et al. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets , 2019, CNS Drugs.
[7] Kirk W. Johnson,et al. CGRP and the Trigeminal System in Migraine , 2019, Headache.
[8] S. Tang,et al. An evidence‐based systematic review of the off‐label uses of lisinopril , 2018, British journal of clinical pharmacology.
[9] M. Kaur,et al. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies , 2018, Cardiovascular Diabetology.
[10] Xiping Liang,et al. Association between Body Mass Index and Migraine: A Survey of Adult Population in China , 2018, Behavioural neurology.
[11] L. Stovner,et al. Inverse relationship between type 1 diabetes mellitus and migraine. Data from the Nord-Trøndelag Health Surveys 1995–1997 and 2006–2008 , 2018, Cephalalgia : an international journal of headache.
[12] Susan W. Broner,et al. Migraine in Women , 2017, Seminars in Neurology.
[13] S. Mohr,et al. Müller cells and diabetic retinopathy , 2017, Vision Research.
[14] N. Sawada,et al. Metabolic Regulation of Angiogenesis in Diabetes and Aging. , 2017, Physiology.
[15] A. Kamshilin,et al. Arterial hypertension in migraine: Role of familial history and cardiovascular phenotype , 2017, Autonomic Neuroscience.
[16] H. Lund‐Andersen,et al. The Danish Registry of Diabetic Retinopathy , 2016, Clinical epidemiology.
[17] J. Manson,et al. Migraine and risk of cardiovascular disease in women: prospective cohort study , 2016, British Medical Journal.
[18] Seyed Masoud Arzaghi,et al. Migraine and type 2 diabetes; is there any association? , 2016, Journal of Diabetes & Metabolic Disorders.
[19] Walter T Ambrosius,et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. , 2014, Ophthalmology.
[20] C. Fernández‐de‐las‐Peñas,et al. Has the Prevalence of Migraine Changed over the Last Decade (2003–2012)? A Spanish Population-Based Survey , 2014, PloS one.
[21] R. Walker,et al. Pioglitazone Normalizes Insulin Signaling in the Diabetic Rat Retina through Reduction in Tumor Necrosis Factor α and Suppressor of Cytokine Signaling 3* , 2014, The Journal of Biological Chemistry.
[22] Juan Wu,et al. STZ treatment induced apoptosis of retinal cells and effect of up-regulation of calcitonin gene related peptide in rats. , 2013, Journal of diabetes and its complications.
[23] K. Oedegaard,et al. Does Diabetes Have a Protective Effect on Migraine? , 2013, Epidemiology.
[24] R. Lipton,et al. Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study , 2012, Headache.
[25] J. Brandes. Migraine in Women , 2012, Continuum.
[26] M. Prentki,et al. Type 2 diabetes across generations: from pathophysiology to prevention and management , 2011, The Lancet.
[27] C. Pedersen,et al. The Danish Civil Registration System , 2011, Scandinavian journal of public health.
[28] J. Hallas,et al. The Danish National Prescription Registry , 2011, Scandinavian journal of public health.
[29] Bing Li,et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.
[30] A. Charles,et al. The Neurogenic Basis of Migraine , 2008, Headache.
[31] P. Martelletti,et al. Genetics of migraine and pharmacogenomics: some considerations , 2007, The Journal of Headache and Pain.
[32] R. Klein,et al. Migraine and retinal microvascular abnormalities , 2007, Neurology.
[33] J. Díez. Arterial stiffness and extracellular matrix. , 2007, Advances in cardiology.
[34] J. Pascual,et al. Epidemiology of headache in Europe , 2006, European journal of neurology.
[35] R. Lipton,et al. Migraine: Epidemiology, Impact, and Risk Factors for Progression , 2005, Headache.
[36] Matthew D. Davis,et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.
[37] Eiji Kohmura,et al. Prediction of Hyperperfusion After Carotid Endarterectomy by Brain SPECT Analysis With Semiquantitative Statistical Mapping Method , 2003, Stroke.
[38] D. Sane,et al. Abnormal angiogenesis in diabetes mellitus , 2003, Medicinal research reviews.
[39] L. Aiello,et al. Systemic considerations in the management of diabetic retinopathy. , 2001, American journal of ophthalmology.
[40] T. Sano,et al. [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[41] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[42] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.